Cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, biological analysis and molecular docking study of sulphur containing heterocyclic analogues

被引:4
|
作者
Ullah, Hayat [1 ]
Rahim, Fazal [2 ]
Uddin, Imad [3 ]
Taha, Muhammad [4 ]
Khan, Misbah Ullah [5 ]
Khan, Fahad [2 ]
Khan, Shoaib [6 ]
Hussain, Rafaqat [2 ]
Hussain, Amjad [1 ]
Iqbal, Naveed [7 ]
Gul, Farzana [8 ]
机构
[1] Univ Okara, Dept Chem, Okara 56130, Pakistan
[2] Hazara Univ, Dept Chem, Mansehra 21300, Khyber Pakhtunk, Pakistan
[3] Univ Haripur, Dept Chem, Haripur 22620, Khyber Pakhtunk, Pakistan
[4] Imam Abdulrahman Bin Faisal Univ, Inst Res & Med Consultat IRMC, Dept Clin Pharm, POB 1982, Dammam 31441, Saudi Arabia
[5] Univ Okara, Ctr Nanosci, Okara 56130, Pakistan
[6] Abbottabad Univ Sci & Technol AUST, Dept Chem, Abbottabad, Pakistan
[7] Univ Poonch, Dept Chem, Rawalakot, Ajk, Pakistan
[8] Hazara Univ, Dept Biochem, Mansehra 21300, Khyber Pakhtunk, Pakistan
来源
CHEMICAL DATA COLLECTIONS | 2024年 / 51卷
关键词
Synthesis; Thiophene; Sulfonamide; Acetylcholinesterase; Butyrylcholinesterase; GLUTATHIONE-S-TRANSFERASE; CARBONIC-ANHYDRASE; ACETYLCHOLINE ESTERASE; ALPHA-GLUCOSIDASE; DERIVATIVES; BUTYRYLCHOLINESTERASE; ANTIOXIDANT; LACTOPEROXIDASE; THIAZOLE; BASES;
D O I
10.1016/j.cdc.2024.101132
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In synthetic medicinal chemistry thiophene and their analogues play a vital role due to the wide range of pharmacological properties. In current studies, we have synthesized a new class of thiophene-bearing sulfonamide analogues (1-11) as cholinesterase inhibitors. These newly synthesized upon esterification, hydrazide formation and finally through sulfonamide mode of synthesis and were characterized through 1H, 13C NMR and HREI-MS spectroscopic techniques. Synthesized analogues showed an excellent to moderate cholinesterase inhibitory potential. Analogues 10, 7, 9 and 11 showed an excellent potency against cholinesterase inhibition as compared to standard Donepezil. The binding interactions of the most potent analogues were confirmed through molecular docking studies. All Compounds were verified for cytotoxicity against 3T3 mouse fibroblast cell line and detected non-toxic.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Multipotent Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease: Synthesis, Biological Analysis and Molecular Docking Study of Benzimidazole-Based Thiazole Derivatives
    Hussain, Rafaqat
    Ullah, Hayat
    Rahim, Fazal
    Sarfraz, Maliha
    Taha, Muhammad
    Iqbal, Rashid
    Rehman, Wajid
    Khan, Shoaib
    Shah, Syed Adnan Ali
    Hyder, Sajjad
    Alhomrani, Majid
    Alamri, Abdulhakeem S.
    Abdulaziz, Osama
    Abdelaziz, Mahmoud A.
    MOLECULES, 2022, 27 (18):
  • [2] Novel asymmetric biscarbothioamides as Alzheimer's disease associated cholinesterase inhibitors: synthesis, biological activity, and molecular docking studies
    Muglu, Halit
    Yakan, Hasan
    Erdogan, Musa
    Topal, Fevzi
    Topal, Meryem
    Turkes, Cuneyt
    Beydemir, Sukru
    NEW JOURNAL OF CHEMISTRY, 2024, 48 (24) : 10979 - 10989
  • [3] Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors
    Parlar, Sulunay
    Bayraktar, Gulsah
    Tarikogullari, Ayse Hande
    Alptuzun, Vildan
    Erciyas, Ercin
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2016, 64 (09) : 1281 - 1287
  • [4] Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease
    Hussein, Weiam
    Saglik, Beguem Nurpelin
    Levent, Serkan
    Korkut, Buesra
    Ilgin, Sinem
    Ozkay, Yusuf
    Kaplancikli, Zafer Asim
    MOLECULES, 2018, 23 (08)
  • [5] Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine
    Samadi, Abdelouahid
    de los Rios, Cristobal
    Bolea, Irene
    Chioua, Mourad
    Iriepa, Isabel
    Moraleda, Ignacio
    Bartolini, Manuela
    Andrisano, Vincenza
    Galvez, Enrique
    Valderas, Carolina
    Unzeta, Mercedes
    Marco-Contelles, Jose
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 52 : 251 - 262
  • [6] Treatment of Alzheimer's disease with cholinesterase inhibitors
    Schneider, LS
    CLINICS IN GERIATRIC MEDICINE, 2001, 17 (02) : 337 - +
  • [7] Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer's disease
    Samadi, Abdelouahid
    Chioua, Mourad
    Bolea, Irene
    de los Rios, Cristobal
    Iriepa, Isabel
    Moraleda, Ignacio
    Bastida, Agatha
    Esteban, Gerard
    Unzeta, Mercedes
    Galvez, Enrique
    Marco-Contelles, Jose
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (09) : 4665 - 4668
  • [8] Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors
    Gao, Cheng-Zhi
    Dong, Wei
    Cui, Zhi-Wen
    Yuan, Qiong
    Hu, Xia-Min
    Wu, Qing-Ming
    Han, Xianlin
    Xu, Yao
    Min, Zhen-Li
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2019, 34 (01) : 150 - 162
  • [9] Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer's Disease: An In Silico Molecular Docking Simulation and ADMET Study
    Jamal, Qazi Mohammad Sajid
    Khan, Mohammad Imran
    Alharbi, Ali H. H.
    Ahmad, Varish
    Yadav, Brijesh Singh
    NUTRIENTS, 2023, 15 (07)
  • [10] Cholinesterase inhibitors for the treatment of Alzheimer's disorder: Synthesis, biological analysis and molecular modelling studies of iso-quinoline derivatives
    Ahmad, Mushtaq
    Uddin, Imad
    Murad, Marukh
    Maryam, Laiba
    Subhan, Zakia
    Khan, Muhammad Saleem
    Nabi, Kainat
    Nabi, Muhammad
    Rahim, Fazal
    Ullah, Hayat
    Rehman, Zia Ur
    Bekhit, Mounir M.
    Alnbaheen, May Salem
    Algarni, Alanood S.
    Aghayeva, Saltanat
    RESULTS IN CHEMISTRY, 2024, 9